Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Irritable Bowel Syndrome, March 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 72 articles:
HTML format


 

Single Articles

  1. KHETPAL N, Yadav L, Khalid S, Kumar R, et al
    Eluxadoline-induced Recurrent Pancreatitis in a Young Female without a Gallbladder: A Case Report and Literature Review.
    Cureus. 2018;10:e3747.
    Abstract    

    Abstract available

  2. JALILI M, Vahedi H, Poustchi H, Hekmatdoost A, et al
    Effects of Vitamin D Supplementation in Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Int J Prev Med. 2019;10:16.
    Abstract    

    Abstract available

  3. LEE TY, Hsieh TC, Sung HC, Chen WL, et al
    Internet-Delivered Cognitive Behavior Therapy for Young Taiwanese Female Nursing Students with Irritable Bowel Syndrome-A Cluster Randomized Controlled Trial.
    Int J Environ Res Public Health. 2019;16.
    Abstract    

    Abstract available

  4. SHI SM, Wen YL, Hou HB, Liu HX, et al
    Effectiveness of vitamin D for irritable bowel syndrome: A protocol for a systematic review of randomized controlled trial.
    Medicine (Baltimore). 2019;98:e14723.
    Abstract    

    Abstract available

  5. KAY E, Hawramee S, Pollani S, Mandel ED, et al
    Nonpharmacologic options for treating irritable bowel syndrome.
    JAAPA. 2019;32:38-42.
    Abstract    

    Abstract available

  6. BHATT RR, Gupta A, Rapkin A, Kilpatrick LA, et al
    Altered Gray Matter Volume in Sensorimotor and Thalamic Regions associated with Pain in Localized Provoked Vulvodynia: A Voxel-based Morphometry Study.
    Pain. 2019 Feb 25. doi: 10.1097/j.pain.0000000000001532.
    Abstract    

    Abstract available

  7. VASANT DH, Whorwell PJ
    Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol.
    Neurogastroenterol Motil. 2019 Feb 27:e13573. doi: 10.1111/nmo.13573.
    Abstract    

    Abstract available

  8. MAVROUDIS G, Simren M, Jonefjall B, Ohman L, et al
    Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease.
    Therap Adv Gastroenterol. 2019;12:1756284819827689.
    Abstract    

    Abstract available

  9. GUREVICH KG, Nikonov EL, Zaborova VA, Shelekhova TY, et al
    [Probiotic using as a part of complex therapy of disbiotic violations at some intestinal diseases].
    Vopr Pitan. 2019;88:77-84.
    Abstract    

    Abstract available

  10. OHKUSA T, Koido S, Nishikawa Y, Sato N, et al
    Gut Microbiota and Chronic Constipation: A Review and Update.
    Front Med (Lausanne). 2019;6:19.
    Abstract    

    Abstract available

  11. ESTREMERA-AREVALO F, Barcelo M, Serrano B, Rey E, et al
    Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis.
    World J Gastroenterol. 2019;25:837-847.
    Abstract    

    Abstract available

  12. KOGAWA AC, Peltonen L, Antonio SG, Salgado HRN, et al
    Submission of Rifaximin to Different Techniques: Characterization, Solubility Study, and Microbiological Evaluation.
    AAPS PharmSciTech. 2019;20:125.
    Abstract    

    Abstract available

  13. CHU L, Valencia IJ, Garvert DW, Montoya JG, et al
    Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Front Pediatr. 2019;7:12.
    Abstract    

    Abstract available

  14. MAZZONE A, Gibbons SJ, Eisenman ST, Strege PR, et al
    Direct repression of anoctamin 1 ( ANO1) gene transcription by Gli proteins.
    FASEB J. 2019 Feb 25:fj201802373R. doi: 10.1096/fj.201802373.
    Abstract    

    Abstract available

  15. YU YC, Li J, Zhang M, Pan JC, et al
    Resveratrol Improves Brain-Gut Axis by Regulation of 5-HT-Dependent Signaling in the Rat Model of Irritable Bowel Syndrome.
    Front Cell Neurosci. 2019;13:30.
    Abstract    

    Abstract available

  16. ILIAS A, Rozsa FP, Gonczi L, Lovasz BD, et al
    [The role of fecal calprotectin in the diagnosis and treatment of gastrointestinal diseases].
    Orv Hetil. 2019;160:322-328.
    Abstract    

    Abstract available

  17. NAKAMORI H, Naitou K, Horii Y, Shimaoka H, et al
    Medullary raphe nuclei activate the lumbosacral defecation center through the descending serotonergic pathway to regulate colorectal motility in rats.
    Am J Physiol Gastrointest Liver Physiol. 2018;314:G341-G348.
    Abstract    

    Abstract available

  18. SCHROEDER J, Karkar R, Fogarty J, Kientz JA, et al
    A Patient-Centered Proposal for Bayesian Analysis of Self-Experiments for Health.
    J Healthc Inform Res. 2019;3:124-155.
    Abstract    

    Abstract available

  19. ALEGBELEYE BJ
    Crohn's disease in a developing African mission hospital: a case report.
    J Med Case Rep. 2019;13:80.
    Abstract    

    Abstract available

  20. KIM JH, Jee SR
    [Irritable Bowel Syndrome].
    Korean J Gastroenterol. 2019;73:84-91.
    Abstract    

    Abstract available

  21. EDWINSON AL, Grover M
    Measurement of novel intestinal secretory and barrier pathways and effects of proteases.
    Neurogastroenterol Motil. 2019;31:e13547.
    Abstract    

    Abstract available

  22. NASSER Y, Petes C, Simmers C, Basso L, et al
    Activation of Peripheral Blood CD4+ T-Cells in IBS is not Associated with Gastrointestinal or Psychological Symptoms.
    Sci Rep. 2019;9:3710.
    Abstract    

    Abstract available

  23. DUCROTTE P, Melchior C
    [Management of functional bowel disorders].
    Rev Prat. 2018;68:18-24.
    Abstract    

    Abstract available

  24. TAFT TH, Bedell A, Craven MR, Guadagnoli L, et al
    Initial Assessment of Post-traumatic Stress in a US Cohort of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Mar 7. pii: 5370427. doi: 10.1093.
    Abstract    

    Abstract available

  25. NYBACKA S, Storsrud S, Liljebo T, Le Neve B, et al
    Within- and Between-Subject Variation in Dietary Intake of Fermentable Oligo-, Di-, Monosaccharides, and Polyols Among Patients with Irritable Bowel Syndrome.
    Curr Dev Nutr. 2018;3:nzy101.
    Abstract    

    Abstract available

  26. SCHNEDL WJ, Lackner S, Enko D, Schenk M, et al
    Evaluation of symptoms and symptom combinations in histamine intolerance.
    Intest Res. 2019 Mar 7. pii: ir.2018.00152. doi: 10.5217/ir.2018.00152.
    Abstract    

    Abstract available

  27. HEINSCH M, Nightingale S
    Integrating psychosocial approaches into the management of childhood functional gastrointestinal disorders: a role for social work.
    Soc Work Health Care. 2019 Mar 5:1-13. doi: 10.1080/00981389.2019.1581871.
    Abstract    

    Abstract available

  28. FRAGKOS KC, Keetarut K, Cox A, Eady J, et al
    Joint Hypermobility Syndrome Affects Response to a Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Irritable Bowel Syndrome Patients: A Retrospective Study.
    Gastroenterology Res. 2019;12:27-36.
    Abstract    

    Abstract available

  29. MIRSHARIFA SM, Mirzaian B, Dousti Y
    The Efficacy of Acceptance and Commitment Therapy (ACT) Matrix on Depression and Psychological Capital of the Patients with Irritable Bowel Syndrome.
    Open Access Maced J Med Sci. 2019;7:421-427.
    Abstract    

    Abstract available

  30. SHAH ED, Saini SD, Chey WD
    Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy.
    Clin Gastroenterol Hepatol. 2019 Mar 1. pii: S1542-3565(19)30245.
    Abstract    

    Abstract available

  31. DUAN R, Zhu S, Wang B, Duan L, et al
    Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing: A Systematic Review.
    Clin Transl Gastroenterol. 2019;10:e00012.
    Abstract    

    Abstract available

  32. PATHIRANA WGW, Chubb SP, Gillett MJ, Vasikaran SD, et al
    Faecal Calprotectin.
    Clin Biochem Rev. 2018;39:77-90.
    Abstract    

    Abstract available

  33. ZHU H, Xiao X, Chai Y, Li D, et al
    MiRNA-29a modulates visceral hyperalgesia in irritable bowel syndrome by targeting HTR7.
    Biochem Biophys Res Commun. 2019 Feb 28. pii: S0006-291X(19)30327.
    Abstract    

    Abstract available

  34. LEE HJ, Kim HJ, Kang EH, Jung KW, et al
    Self-reported Food Intolerance in Korean Patients With Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2019 Feb 14. pii: jnm18125. doi: 10.5056/jnm18125.
    Abstract    

    Abstract available

  35. MCWHIRTER L, Miller N, Campbell C, Hoeritzauer I, et al
    Understanding foreign accent syndrome.
    J Neurol Neurosurg Psychiatry. 2019 Mar 2. pii: jnnp-2018-319842.
    Abstract    

    Abstract available

  36. NATH A, Shope TR, Brebbia JS, Koch TR, et al
    Bowel symptoms are associated with hypovitaminosis D in individuals with medically complicated obesity.
    Nutr Res. 2019;63:70-75.
    Abstract    

    Abstract available

  37. GRACE S, Barnes L, Reilly W, Vlass A, et al
    An integrative review of dietetic and naturopathic approaches to functional bowel disorders.
    Complement Ther Med. 2018;41:67-80.
    Abstract    

    Abstract available

  38. HUERTA PA, Cifuentes M, Levenstein C, Kriebel D, et al
    The Association of Occupational Psychosocial Factors with the Prevalence of Irritable Bowel Syndrome in the Chilean Working Population.
    Ann Work Expo Health. 2019 Mar 16. pii: 5381924. doi: 10.1093.
    Abstract    

    Abstract available

  39. FRIELING T, Heise J, Krummen B, Hundorf C, et al
    Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course.
    Z Gastroenterol. 2019 Mar 14. doi: 10.1055/a-0859-7531.
    Abstract    

    Abstract available

  40. JIANG C, Xu Y, Sharma S, Zhang L, et al
    Psychosocial Factors Associated With Irritable Bowel Syndrome Development in Chinese College Freshmen.
    J Neurogastroenterol Motil. 2019 Mar 8. pii: jnm18028. doi: 10.5056/jnm18028.
    Abstract    

    Abstract available

  41. SUAREZ GONZALEZ M, Diaz Martin JJ, Jimenez Trevino S, Bousono Garcia C, et al
    [Effect of healthy eating before intervention with a low FODMAP diet in pediatric patients with irritable bowel syndrome].
    Nutr Hosp. 2019 Mar 15. doi: 10.20960/nh.2234.
    Abstract    

    Abstract available

  42. PERSON H, Keefer L
    Brain-Gut Therapies for Pediatric Functional Gastrointestinal Disorders and Inflammatory Bowel Disease.
    Curr Gastroenterol Rep. 2019;21:12.
    Abstract    

    Abstract available

  43. CAI H, Xu Y, Xie L, Duan Y, et al
    Investigation on Spectrum-Effect Correlation between Constituents Absorbed into Blood and Bioactivities of Baizhu Shaoyao San before and after Processing on Ulcerative Colitis Rats by UHPLC/Q-TOF-MS/MS Coupled with Gray Correlation Analysis.
    Molecules. 2019;24.
    Abstract    

    Abstract available

  44. CORSETTI M, Pannemans J, Whorwell P
    Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders?
    F1000Res. 2019;8.
    Abstract    

    Abstract available

  45. VOJDANI A, Vojdani E
    Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens.
    World J Gastroenterol. 2019;25:1050-1066.
    Abstract    

    Abstract available

  46. SISTANI KARAMPOUR N, Arzi A, Rezaie A, Pashmforoosh M, et al
    Gastroprotective Effect of Zingerone on Ethanol-Induced Gastric Ulcers in Rats.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  47. GALVEZ-SANCHEZ CM, Duschek S, Reyes Del Paso GA
    Psychological impact of fibromyalgia: current perspectives.
    Psychol Res Behav Manag. 2019;12:117-127.
    Abstract    

    Abstract available

  48. AGUILERA-LIZARRAGA J, Florens MV, Van Brussel T, Clevers E, et al
    Expression of immune-related genes in rectum and colon descendens of Irritable Bowel Syndrome patients is unrelated to clinical symptoms.
    Neurogastroenterol Motil. 2019 Mar 10:e13579. doi: 10.1111/nmo.13579.
    Abstract    

    Abstract available

  49. TAN LH, Li KG, Wu YY, Guo MW, et al
    Effect of Electroacupuncture at Different Acupoints on the Expression of NMDA Receptors in ACC and Colon in IBS Rats.
    Evid Based Complement Alternat Med. 2019;2019:4213928.
    Abstract    

    Abstract available

  50. NEDELCU L
    A difficult path in the management of irritable bowel syndrome: from general recommendations to clinical reality.
    J Gastrointestin Liver Dis. 2019;28:132.
    Abstract    



  51. GUADAGNOLI L, Mutlu EA, Doerfler B, Ibrahim A, et al
    Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome.
    Qual Life Res. 2019 Mar 21. pii: 10.1007/s11136-019-02170.
    Abstract    

    Abstract available

  52. CROWE SE
    Food Allergy Vs Food Intolerance in Patients With Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2019;15:38-40.
    Abstract    



  53. WERLANG ME, Palmer WC, Lacy BE
    Irritable Bowel Syndrome and Dietary Interventions.
    Gastroenterol Hepatol (N Y). 2019;15:16-26.
    Abstract    

    Abstract available

  54. LICHTENSTEIN GR
    Food and Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2019;15:7.
    Abstract    



  55. JIN S, Li YF, Qin D, Luo DQ, et al
    Non-pharmacological treatments for irritable bowel syndrome: study protocol of an umbrella review of systematic review and meta-analyses.
    BMJ Open. 2019;9:e027778.
    Abstract    

    Abstract available

  56. LABUS JS, Osadchiy V, Hsiao EY, Tap J, et al
    Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.
    Microbiome. 2019;7:45.
    Abstract    

    Abstract available

  57. AKSOY EK, Cetinkaya H, Savas B, Ensari A, et al
    Vascular endothelial growth factor, endostatin levels and clinical features among patients with ulcerative colitis and irritable bowel syndrome and among healthy controls: a cross-sectional analytical study.
    Sao Paulo Med J. 2018;136:543-550.
    Abstract    

    Abstract available

  58. DE SANCTIS V, Abbasciano V, Soliman AT, Soliman N, et al
    The juvenile fibromyalgia syndrome (JFMS): a poorly defined disorder.
    Acta Biomed. 2019;90:134-148.
    Abstract    

    Abstract available

  59. WANG XJ, Camilleri M
    Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy.
    World J Gastroenterol. 2019;25:1185-1196.
    Abstract    

    Abstract available

  60. SALEM AI, El-Taweel HA, Madkour MA, Abd El-Latif NF, et al
    Irritable bowel syndrome in Egyptian patients: plausible risk factors and association with intestinal protozoa.
    Trop Doct. 2019 Mar 18:49475519837112. doi: 10.1177/0049475519837112.
    Abstract    

    Abstract available

  61. WANG Z, Xu CM, Liu YX, Wang XQ, et al
    Characteristic dysbiosis of gut microbiota of chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Chin Med J (Engl). 2019 Mar 4. doi: 10.1097/CM9.0000000000000192.
    Abstract    

    Abstract available

  62. OLESEN JA, Posselt CM, Poulsen CH, Nordentoft M, et al
    Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls.
    Psychol Med. 2019 Mar 18:1-8. doi: 10.1017/S0033291719000370.
    Abstract    

    Abstract available

  63. MARI A, Abu Backer F, Mahamid M, Amara H, et al
    Bloating and Abdominal Distension: Clinical Approach and Management.
    Adv Ther. 2019 Mar 16. pii: 10.1007/s12325-019-00924.
    Abstract    

    Abstract available

  64. STEURER J

    Praxis (Bern 1994). 2018;107:1289-1290.
    Abstract    



  65. WILKINSON JM, Cozine EW, Loftus CG
    Gas, Bloating, and Belching: Approach to Evaluation and Management.
    Am Fam Physician. 2019;99:301-309.
    Abstract    

    Abstract available

  66. SCHMULSON M
    Is Post Infection-Irritable Bowel Syndrome Less Frequent in Mexico?
    Am J Gastroenterol. 2019 Jan 21. doi: 10.14309/ajg.0000000000000098.
    Abstract    



  67. B BIOMED GB, Carroll G, Mathe A, Horvat J, et al
    Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.
    Am J Gastroenterol. 2019;114:429-436.
    Abstract    

    Abstract available

  68. HORIKAWA T, Oshima T, Li M, Kitayama Y, et al
    Chenodeoxycholic Acid Releases Proinflammatory Cytokines from Small Intestinal Epithelial Cells Through the Farnesoid X Receptor.
    Digestion. 2019 Mar 7:1-9. doi: 10.1159/000496687.
    Abstract    

    Abstract available

  69. ADEJUMO AC, Ajayi TO, Adegbala OM, Bukong TN, et al
    Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis.
    Eur J Gastroenterol Hepatol. 2019 Feb 21. doi: 10.1097/MEG.0000000000001382.
    Abstract    

    Abstract available

  70. ALLEGRETTI JR, Kassam Z, Fischer M, Kelly C, et al
    Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT).
    J Clin Gastroenterol. 2019 Mar 13. doi: 10.1097/MCG.0000000000001194.
    Abstract    

    Abstract available

  71. WONG MW, Bair MJ, Chang WC, Hsu CS, et al
    Clinical and psychological characteristics in GERD patients overlapping with laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2019 Mar 8. doi: 10.1111/jgh.14651.
    Abstract    

    Abstract available

  72. MAK DPA, Chung CHV, Suet Ying Y, Tse YK, et al
    Electroacupuncture is Not Effective For Comorbid Generalized Anxiety Disorder & Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2019 Mar 19. doi: 10.1111/jgh.14667.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;